Table 2 Association between clinical characteristics and DDR gene mutations in advanced NSCLC patients
Negative | Positive | Odd ratio | P value | |
|---|---|---|---|---|
Age | ||||
< 65 | 20 | 13 | 1.19 | 1 |
>=65 | 9 | 7 | ||
Gender | ||||
female | 8 | 7 | 0.71 | 0.75 |
male | 21 | 13 | ||
Smoking history | ||||
Never_smoking | 13 | 13 | 0.45 | 0.24 |
Smoking | 16 | 7 | ||
Tumor size | ||||
Small | 12 | 12 | 0.48 | 0.25 |
Big | 17 | 8 | ||
Metastasis | ||||
Never_metastasis | 2 | 6 | 0.18 | 0.0497 |
Metastasis | 27 | 14 | ||
Therapy | ||||
Platinum-based chemotherapy/immunotherapy | 21 | 11 | 2.97 | 0.11 |
Platinum-based chemotherapy | 5 | 8 |